186 results
Page 3 of 10
10-K
EX-10.20
vt6dgzp43md010n
12 Feb 18
Annual report
12:00am
10-K
EX-10.51
ihm syz51
12 Feb 18
Annual report
12:00am
424B5
12xjav6rh t5b
18 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
72nqirswfeu u90g
13 Jul 16
Current report (foreign)
12:00am
6-K
31r3qs1x5ti9or 0k
30 Nov 15
Current report (foreign)
12:00am
424B5
8rb4k fim
30 Nov 15
Prospectus supplement for primary offering
12:00am
424B5
kc0yg4o2wzhiqqjt2
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
07g01 4uzm
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
425
5da3w25fnbo p4y04r54
8 Jun 15
Business combination disclosure
12:00am
425
tvuxskp5i z7c
21 Apr 15
Business combination disclosure
12:00am
6-K
EX-99.1
ajv1sd3f
21 Apr 15
Teva Proposes to Acquire Mylan for $82.00 Per Share In Cash and Stock
12:00am
6-K
2sm5ed5v s07
30 Oct 14
Current report (foreign)
12:00am
6-K
EX-99.1
e0twbw8
3 Jun 14
Live Filing
12:00am
6-K
hdrxqpjqmy15bpn
31 Oct 13
Current report (foreign)
12:00am
6-K
EX-99.1
4nnuc47q65e9c9y
1 Aug 13
Teva Reports Second Quarter 2013 Results
12:00am
6-K
0qxqlmwbl j08
2 May 13
Current report (foreign)
12:00am